Dhanvanthri Super Speciality Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 05-12-2024
- Paid Up Capital ₹ 0.10 M
as on 05-12-2024
- Company Age 1 Year 4 Months
- Satisfied Charges ₹ 25.00 Cr
as on 05-12-2024
About Dhanvanthri Super Speciality
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹25.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Guttahalli Shridhar, Kaushik Natesan, Amit Bishnoi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U46497KA2023PTC177243
- Company No.
177243
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
11 Aug 2023
- Date of AGM
-
- Date of Balance Sheet
-
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Company Details
- Location
Bangaluru, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Dhanvanthri Super Speciality?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Guttahalli Shridhar  | Whole-Time Director | 11-Aug-2023 | Current |
| Kaushik Natesan | Additional Director | 11-Dec-2023 | Current |
| Amit Bishnoi | Additional Director | 26-Feb-2024 | Current |
| Sambit Mohanty | Additional Director | 11-Dec-2023 | Current |
| Bhavya Balaraj | Whole-Time Director | 11-Aug-2023 | Current |
Financial Performance and Corporate Structure Insights of Dhanvanthri Super Speciality.
Enhance accessibility to Dhanvanthri Super Speciality's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dhanvanthri Super Speciality?
Unlock access to Dhanvanthri Super Speciality's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Novacare Healthcare Solutions Private LimitedActive 6 years 6 monthsSambit Mohanty is a mutual person
Dhanvanthri Speciality Pharma Private LimitedActive 9 years 8 monthsGuttahalli Shridhar and Bhavya Balaraj are mutual person
Quromed Lifesciences Private LimitedActive 4 years 8 monthsKaushik Natesan and Amit Bishnoi are mutual person
- Chethana Pharma Distributors Private LimitedActive 4 years 8 months
Kaushik Natesan is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 19 Dec 2023 | ₹25.00 Cr | Satisfied |
How Many Employees Work at Dhanvanthri Super Speciality?
Unlock and access historical data on people associated with Dhanvanthri Super Speciality, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dhanvanthri Super Speciality, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dhanvanthri Super Speciality's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.